Prepare for your visit

Angela Taber

Hematology & Oncology · Providence, RI · NPI 1912124454

One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.

What was reported

$1,980.03

in general payments reported to CMS, 2019-2025 · $601 in 2025

The $601 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).

Who reported paying

General payments only, top 6 by amount.

Astrazeneca Pharmaceuticals LP $209.71
Merck Sharp & Dohme LLC $198.69
Astellas Pharma US INC $183.47
Pfizer INC. $177.00
Progenics Pharmaceuticals, INC. $147.13
Sobi, INC $125.79

Drugs and devices associated with these payments

Keytruda Pylarify Padcev Lynparza Reblozyl Enhertu Adcetris Elrexfio Imbruvica Orgovyx Imfinzi Opdivo

Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.

Questions you might ask

I saw Angela Taber listed in the CMS Open Payments database. Can you tell me about your work with those companies?
Is there a generic or alternative to this medication, and would it work as well for me?
What made you choose this particular treatment for my situation?

These are normal questions. A good clinician will welcome them.

Notes

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.

GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/1243175/angela-taber